Tyroserleutide

DB17300InvestigationalSmall molecule

Tyroserleutide: Overview.

Chemical structure of Tyroserleutide
Formula / weight
C18H27N3O6 · 381.429 g/mol (avg)
Also known as
L-leucine, l-tyrosyl-l-seryl- · L-tyrosine-l-serine-l-leucine
Code names
CMS-024

Resolves to

Compound
UNIIL9TIM50J8NCAS138168-48-6ChEBI165965
Structure
InChIKeyMQGGXGKQSVEQHR-KKUMJFAQSA-NSMILESCC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1)C(O)=O

What you can answer from here — as of December 03, 2022

1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Tyroserleutide, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In